I. What is euroPLX?
What is euroPLX (short for "European Pharma License Exchange")?
euroPLX is an international platform for pharma and biopharma executives who are in charge of business development and licensing in and out of
- approved patented or generic drugs (incl. biosimilars)
- early to late stage (ph. I and up) drug developments
- OTC drugs and dietary supplements
- medical devices
- technologies applicable to marketed drugs or late stage drug developments.
euroPLX Meetings feature a scope of collaborative agreements from development to licensing, marketing, promotion, and distribution.
In addition, attending companies frequently offer or look for R&D services, supporting technologies (drug delivery, medical devices), contract manufacture, and, to some extent, the supply of APIs and intermediates.
The actual focus of each meeting is determined by the participating companies’ business interests and is displayed as a "Dynamic Partnering Focus" on www.europlx.com as delegates submit the necessary data.
The meeting frequency (3 times per year) provides a time-to-market oriented instrument to follow up on negotiations in a timely manner.
What is so special about euroPLX Meetings?
Their focus on people, purpose, and effectiveness:
- Business Developers and Licensing Executives, or Brokers/Consultants with a clear mandate are accepted only. Strictly no other audience.
- Business appointments only. No lectures, presentations, keynotes, and other distracting features.
- With more than 20 pre-scheduled appointments per 2-day event, euroPLX Meetings are more efficient than any other partnering event, resulting in higher effectiveness of our clients’ attendance.
Delegates' Comments
Dr. Norbert Rau
Paul Phull
Anke Rau and Dr. Norbert Rau
Sebastien Sanial and Malgorzata Derewianka
Dr. Peter Komnick and Dr. Silke Behne
Rich DiCicco
Kees Trommelen
Dragan Lutz and Mario Vlasic
Dr. Satyendra Kumar
Peter van Hoogstraten and Paul C. Borghouts
Ronald Kriek and Wouter Hanegraaf
Simona Aganovic and Guy Clark
Vilas Nagare and Sundeep V. Bambolkar
Jinang Parekh and Vijay Agarwal
Dr. Hubert Ridolphi and Dr. Gerrit Hagens
pharmaceutical business…"
Gilbert Adatte
Ramon Brusco
Patrick Tichy
Daniel Jones
Nuray Acar and Mutlu Topal
Ruud Koolen
Ana Paula Branco and José Roberto Pereira
David Zubeldía
Gustavo Samojeden and Hernán Bouzada
Dietmar Jannaschk and Gemma Mogas
Marc Alvarez
Sylvie Fondanayche
Holger and Kai Schleenhain
Reynhardt Van As
Santiago, Mar, and Josémaria Calzada
Agnes Olszanowski and Dr. Marian Takac
Wendell Clayton
Rich DiCicco
Andreas Wagner & Michel Blanc
Wolfgang Bäurle
Patsy Carney
Roland Brown
Elzbieta Weston & Jacek Plucienniczak